Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Maravai Lifesciences Holdings Inc Cl A (NQ: MRVI )

7.890 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Maravai Lifesciences Holdings Inc Cl A

< Previous 1 2 Next >
Maravai LifeSciences to Host 2023 Investor R&D Day
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports Second Quarter 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces Appointment of New Director to the Board
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Congressman Scott Peters Tours Maravai’s RNA manufacturing facility
Congressman Peters (D-CA-50) tours Wateridge manufacturing site in San Diego and celebrates Maravai’s impact in COVID vaccine production 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
From TriLink BioTechnologies
Via Business Wire
TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog
Newest cap analog product improves mRNA potency with greater protein expression, offers time and cost savings, and streamlines manufacturing to drive critical therapeutic and vaccine development 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports First Quarter 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
Updates Revenue, Adjusted EBITDA and Adjusted EPS Guidance for 2022 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Maravai LifeSciences Announces CEO Leadership Transition
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.